Titan Medical (TMDIF) Competitors

AVITA Medical (NASDAQ:RCEL) and Titan Medical (NASDAQ:TMDIF) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, earnings, risk, community ranking, media sentiment and valuation.

Do insiders and institutionals hold more shares of RCEL or TMDIF?

27.7% of AVITA Medical shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 1.8% of AVITA Medical shares are owned by company insiders. Comparatively, 0.0% of Titan Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Does the MarketBeat Community favor RCEL or TMDIF?

AVITA Medical received 78 more outperform votes than Titan Medical when rated by MarketBeat users.

Company	Underperform	Outperform
AVITA Medical	Outperform Votes 78 69.03%	Underperform Votes 35 30.97%
Titan Medical	N/A	N/A

Is RCEL or TMDIF more profitable?

Titan Medical has a net margin of 0.00% compared to AVITA Medical's net margin of -95.47%. Titan Medical's return on equity of -82.31% beat AVITA Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AVITA Medical	-95.47%	-194.69%	-60.67%
Titan Medical	N/A	-82.31%	-51.47%

Which has more risk and volatility, RCEL or TMDIF?

AVITA Medical has a beta of 1.58, suggesting that its stock price is 58% more volatile than the S&P 500. Comparatively, Titan Medical has a beta of 1.26, suggesting that its stock price is 26% more volatile than the S&P 500.

Does the media refer more to RCEL or TMDIF?

In the previous week, AVITA Medical had 2 more articles in the media than Titan Medical. MarketBeat recorded 2 mentions for AVITA Medical and 0 mentions for Titan Medical. AVITA Medical's average media sentiment score of 0.68 beat Titan Medical's score of 0.00 indicating that AVITA Medical is being referred to more favorably in the media.

Company	Overall Sentiment
AVITA Medical	Positive
Titan Medical	Neutral

Do analysts rate RCEL or TMDIF?

AVITA Medical currently has a consensus target price of $18.00, indicating a potential upside of 106.59%. Given AVITA Medical's stronger consensus rating and higher possible upside, research analysts clearly believe AVITA Medical is more favorable than Titan Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AVITA Medical	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Which has preferable valuation and earnings, RCEL or TMDIF?

Titan Medical has lower revenue, but higher earnings than AVITA Medical. AVITA Medical is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AVITA Medical	$50.14M	4.56	-$35.38M	-$2.23	-3.91
Titan Medical	$17.63M	3.30	$6.95M	$0.05	10.20

Summary

AVITA Medical beats Titan Medical on 11 of the 17 factors compared between the two stocks.